Frost & Sullivan is conducting a three-day international conference titled "Global Life Science Molecules: Emerging Opportunities," from 3-5, June 2005, in Goa.

This conference will focus on recent developments in the global active pharmaceutical ingredients (API)/ intermediate industry in the key areas of R&D, strategic partnerships, manufacturing excellence & methodologies, and marketing strategies.

On the first two days of the conference, international stalwarts and decision makers from leading companies such as Lonza Group Ltd, DSM Pharma Chemicals, Cambrex Corporation, LANXESS, and Teva Pharmaceutical Industries, will share their knowledge and address business issues on various topics. These topics will cover relevant themes such as the opportunities that exist in outsourcing, technology licensing and contract research, critical factors considered for partner selection, opportunities for emerging technologies in drug manufacturing, and strategies for global leadership. These will be interspersed with panel discussions addressing the most relevant issues of the industry, officials informed.

Contact Details:
Radhika Chhabria- Account Executive
P: +91 (22) 2832 4705
F: +91 (22) 2832 4713
E: rchhabria@frost.com